AWHL insider transaction filings
Aspira Women's Health Inc. — 23 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen AWHL transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4/A | Strahley John — Chief Financial Officer | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2026-07-15 | 4 | Strahley John — Chief Financial Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 222,222 @ $0.45 · Purchase (P): 300,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | cohen Jeffrey k — Director | Other (J): 11,112 @ $0.45 | EDGAR |
| 2026-05-29 | 4/A | cohen Jeffrey k — Director | Purchase (P): 55,556 @ $0.45 · Purchase (P): 41,667 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4/A | Fraser John D — Director | Purchase (P): 16,389 @ $0.45 · Purchase (P): 12,292 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | Hundorfean Cynthia D — Director | Grant/award (A): 238,085 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | Fraser John D — Director | Grant/award (A): 314,811 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | cohen Jeffrey k — Director | Grant/award (A): 213,518 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Beausang Ellen — Director | Grant/award (A): 198,097 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Parnell Winfred — Director | Grant/award (A): 185,178 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Wood Jane Pine — Director | Grant/award (A): 135,592 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | cohen Jeffrey k — Director | Purchase (P): 55,556 @ $0.45 · Purchase (P): 41,667 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | Fraser John D — Director | Purchase (P): 16,389 @ $0.45 · Purchase (P): 12,292 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 1,111,111 @ $0.45 · Purchase (P): 833,333 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Hungerford Brian — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Ragard John Phillip — Director | Option exercise (M): 4,844 @ $0 · Option exercise (M): 4,844 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Vos Ellen O'Connor — Director | Option exercise (M): 5,312 @ $0 · Option exercise (M): 5,312 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Beausang Ellen — Director | Option exercise (M): 4,843 @ $0 · Option exercise (M): 4,843 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Parnell Winfred — Director | Option exercise (M): 5,156 @ $0 · Option exercise (M): 5,156 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Herchuk Jannie Prestridge — Director | Option exercise (M): 8,437 @ $0 · Option exercise (M): 8,437 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cavanaugh Stefanie L. — Director | Option exercise (M): 5,937 @ $0 · Option exercise (M): 5,937 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | cohen Jeffrey k — Director | Grant/award (A): 44,260 @ $0.07 · Grant/award (A): 11,653 @ $0.07 | EDGAR |
Recent 8-K events — Aspira Women's Health Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-25 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AWHL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →